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Tissue engineering (TE) and regenerative medicine are interdisciplinary fields that provide new 
regenerated tissues by the development of biological substitutes that restore, maintain and or improve 
tissue function. 
Dental pulp stem cells (DPSCs) and gingival mesenchymal stem cells (GMSCS) are a valuable source 
of stem cells for bone tissues regeneration.  
The main objective of the present study is to evaluate the ability of DPSCs and GMSCs harvested from 
periodontally-affected teeth to produce in vitro and in vivo new mineralized bone tissue, in comparison 
to healthy teeth. 
 
 
Weefsel engineering (TE) en regeneratieve geneeskunde zijn interdisciplinaire vakgebieden die samen 
zorgen voor weefselregeneratie door de ontwikkeling van biologische alternatieven die de 
weefselfunctie herstellen, onderhouden en verbeteren. 
Dentale pulpa stamcellen (DPSCs) en gingivale mesenchymale stamcellen (GMSCs) zijn waardevolle 
bronnen voor stamcellen voor botweefsel regeneratie. 
Het hoofddoel van de huidige studie is om de capaciteit na te gaan van deze DPSCs en GMSCs, 
geoogst uit periodontaal aangetaste tanden, om in vitro en in vivo nieuw gemineraliseerd botweefsel te 





















                                          Summary (Informative Abstract) 
 
Dental pulp stem cells (DPSCs) and gingival mesenchymal stem cell (GMSCs) represent an alternative 
source of mesenchymal stem cells, their features make them ideal for bone tissue engineering. In this 
study, we verified the ability of DPSCs and GMSCs harvested from periodontally compromised teeth 
to produce in vitro and in vivo new mineralized bone tissue, in comparison to healthy teeth. 
Initially, we isolate DPSCs and GMSCs from dental pulp and gingiva harvested from patients suffering 
of severe periodontitis (Test group) and from healthy patients (Control group). To characterize DPSCs 
and GMSCs colony-forming assay and cytofluorimetric and mRNA real time quantification analysis 
were performed. The effects of pro-inflammatory cytokines on MSC cell proliferation and 
differentiation potential were investigated. Furthermore, we investigated the capability of DPSCs and 
GMSCs to colonize Poly-L-lactic Acid (PLLA) scaffolds, produced by mean of Thermally Induced 
Phase Separation technique (TIPS). Finally, we investigate the capability of DPSCs and GMSCs from 
both studied groups to induce bone formation in vivo. 
Our findings provide evidence that tissue (both pulp and gingiva) from periodontally-compromise teeth 
can be used as source of MSCs with intact stem properties and increased differentiation potential. Pro-
inflammatory cytokines activate a cytoskeleton remodeling by recruiting heat shock proteins (HSPs) 
including HSP90, HSPA9, thioredoxin-1and actin-depolymerizing factors (ADFs) as profilin-1, cofilin-
1 and vinculin that probably mediated the advantage acquisition in inflamed environment. Moreover, 
the DPSCs and GMSCs have been shown the capability to colonize successfully the PLLA scaffolds, 
but, in the animal study group, we did not observe new bone formation. Indeed, new in vivo studies are 
ongoing: PLLA scaffolds with DPSCs or GMSCs were implanted, in order to provide a more stable 
osteoinductive and osteoconductive structural support. 
 
 
Dentale pulpa stamcellen (DPSCs) en gingivale mesenchymale stamcellen (GMSCs) 
vertegenwoordigen een alternatieve bron voor mesenchymale stamcellen. De eigenschappen van deze 
celtypes maken hun tot ideale kandidaten voor botweefsel engineering. In deze studie gingen we na of 
DPSCs en GMSCs, geoogst uit periodontaal aangetaste tanden, in staat zijn om in vitro en in vivo 
nieuw gemineraliseerd botweefsel te genereren, in vergelijking met gezonde tanden.  
Eerst isoleerden we DPSCs en GMSCs uit de dentale pulpa en gingiva van patiënten die leden aan 
ernstige periodontitis (test groep) en gezonde patiënten (controle groep). Om deze DPSCs en GMSCs te 
karakteriseren voerden we de kolonie-vormende assay, cytofluorimetrische en mRNA real-time 
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kwantificatie analyses uit. Vervolgens werden de effecten van pro-inflammatoire cytokines op de 
proliferatie en differentiatie van MSC cellen onderzocht. Verder onderzochten we de capaciteit van 
DPSCs en GMSCs om Poly-L melkzuur (PLLA) substraat te koloniseren, dat geproduceerd werd door 
de thermaal geïnduceerde fasescheidingstechniek (TIPS). Tenslotte onderzochten we de capaciteit van 
DPSCs en GMSCs van beide studiegroepen om botvorming te induceren in vivo. 
Onze resultaten bewezen dat weefsels (zowel uit de pulpa als uit de gingiva) uit periodontaal aangetaste 
tanden gebruikt kunnen worden als een bron voor MSCs met intacte stamceleigenschappen en 
verhoogd differentiatiepotentieel. Pro-inflammatoire cytokines activeren een cytoskelet herschikking 
door hitteschok eiwitten (HSPs) te rekruteren, zoals HSP90, HSPA9, thioredoxin-1 en actine-
depolymeriserende factoren (ADF) zoals profilin-1, cofilin-1 en vinculin die waarschijnlijk de 
voordelen van een inflammatoire omgeving regelen. Bovendien vertoonden DPSCs en GMSCs de 
capaciteit om met succes PLLA substraten te koloniseren, maar in de dierlijke studiegroep hebben we 
geen nieuwe botformatie geobserveerd. Nieuwe in vivo studies worden momenteel uitgevoerd: PLLA 
substraten die DPSCs of GMSCs bevatten, werden geïmplanteerd om meer stabiele osteoïnductieve en 




























1.1 Restoring missing teeth and bone resorption 
Missing teeth and supporting oral tissues have traditionally been replaced with dentures or bridges 
permitting restoration of chewing function, speech, and aesthetics1,2.  
In the last decades, the use of dental implants has been increasingly applied to replace the missing 
teeth; indeed, today, dental implants are defined as the first-choice treatment modality for replacing 
missing teeth3,4. 
Historically, osseo-integration was firstly described by Branemark 1977 and is defined as the direct 
structural and functional connection between living bone and implant surface5,6. The achievement and 
the maintenance of osseo-integration is linked with implant stability, essential for successful long-terms 
results7,8. 
Implant stability is obtained mechanically during the insertion of the fixture in the jawbones; 
subsequently, the bone remodelling around the implants create a direct structural and functional 
connection between living bone and implant surface6,8,9. 
A sufficient bone volume to achieve primary implant stability is needed to place dental implants; 
however, bone resorption is a pathophysiological process induced by many mechanisms. 
Primarly, the main cause of jawbone resorption is related to tooth loss, other factors that may influence 
the bone anatomy are trauma, surgery or congenital malformation. In particular, Dental caries and 
periodontal disease are the major causes for tooth loss10-12.  
 
1.2 Bone regeneration procedures 
Successful repair of bone deficiencies is a major concerning topic in the oro-maxillo-facial (OMF) 
field. To restore the bone tissue volume is challenging because oro-facial functions, such chewing and 
swallowing, are delicate, due to the complex anatomical structures of the jawbones and the oral 
mucosa3,13-15. 
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Guided bone regeneration (GBR) procedures have become everyday treatment in order to allow the 
placement of dental implants or the periodontal regeneration; GBR is based on the application of 
membranes and grafting materials16,17. 
To achieve a successful GBR, there are various indications, different alternative techniques, and 
numerous ’biologically active’ agents and biomaterials currently used in dental practice16-19. 
Mostly of GBR techniques require special barrier membranes to protect defects from the ingrowth of 
soft tissue cells so that bone progenitor cells may develop bone uninhibited. Membranes can be 
resorbable or non-resorbable; resorbable are usually made by polylactic acid (PLA) or L-polylactic acid 
(PLLA), porcine collagen or polyglactin. Non-resorbable membranes are usually made by titanium-
reinforced expanded polytetrafluoroethylene (e-PTFE)20. 
Among the graft materials there are more options, autogenous bone grafts are considered to be the 
material of choice for GBR, indeed it is defined as the “gold standard”, as it has the biocompatibility, 
osteoinductive and osteoconductive properties, without immunological reactions and extra costs for 
purchasing biomaterials21-23. However, their use leads to an additional surgical intervention, possible 
complication of the donor site and a limited amount of graft21-23. 
Other bone substitutes are: allografts, xenografts or alloplastic graft materials. 
Both of these three substitutes possess advantages and disadvantages, and they can be used in 
combination with autografts or alone, according to the chosen GBR technique17,19,22.  
 
1.3 Tissue Engineering and Regenerative medicine 
Tissue engineering (TE) and regenerative medicine (RM) are emerging fields focused on the 
development of alternative strategies for tissue or organ repair that made significant progress in the last 
years24,25. 
TE provide new regenerated tissues by the appliance of cells, scaffold and growth factors, alone or in 
combination; nowadays RM has made exceptional progress leading to the regeneration of numerous 
organs and organ systems by using the capability of stem cells to differentiate into specialized cell 
types26-28. 
Stem cells are promising tools for tissue repair, due to their extensive proliferation and differentiation 
plasticity, unique ability that make them able, in theory, to regenerate injured tissues24,29.  
Stem-cell-based bone tissue engineering has demonstrated potential; the ideal cell populations are 
autologous mesenchymal stem cells (MSCs) from adult sources30.  
Defined as a population of non-hematopoietic fibroblast-like cells, MSCs are a self-renewing 
populations which express the ability to differentiate into multiple lineages, including osteoblasts, 
adipocytes and chondrocytes24,31,32.  
The main difficulties of the use of MSCs remains the identification of accessible sites within the human 
body where can be collected an adequate amount of stem cells. Indeed, the number of MSCs is higher 
before the birth, but it decreases during the aging, reducing their presence in several “niches”24,31,32. 
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MSCs they have been usually isolated from bone marrow and are defined as bone-marrow-derived 
mesenchymal stem cells (BM-MSCs), but the BM-MSCs possess some weakness, such as their 
difficulty of isolation, large trauma, high expense, and patient’s low degree reception33,34. 
Recently, many niches of MSCs have been described in the oral cavity: the dental pulp from permanent 
(DPSCs) or deciduous teeth (SHED), the periodontal ligament (PDL), the apical papilla, the dental 
follicle and the gingival tissue (GMSCs)35-39. 
 
1.4 Dental pulp stem cells 
DPSCs have been described for the first time by Gronthos et al in the 2000, which described the 
presence of neural crest-derived stem cells from the dental pulp of adult human body35. 
Neural crest-derived stem cells originate from the process that give rise to the dental laminae during the 
sixth week of the embryogenesis, when the ectoderm begins to proliferate. The ectoderm-mesoderm 
interactions lead to the development of tooth germs, where neural crest cells differentiate into the dental 
organ, dental papilla and dental follicle.  
Consequently, dental pulp develops from both ectodermic and mesenchymal components, containing 
neural crest cells. These adult stem cells have been called DPSCs, when isolated from permanent teeth; 
while, when isolated from deciduous teeth, they are defined SHEDs (Stem Cells from Human 
Exfoliated Deciduous)26.  
As well as MSCs, DPSCs and SHEDs are clonogenic cells capable of both self-renewal and the 
capability to give rise to different specialized cell types40. 
Moreover, compared to the BM-MSCs, DPSCs and GMSCs are easier to be harvested and have 
demonstrated the ability to proliferate faster, to be mostly homogenous and to have excellent capacity 
to differentiate in osteogenic cells33-35,40. 
Indeed, since their first isolation, DPSCs and SHEDs have been widely investigated for their potential 
application in TE in the last decades; in vitro and in vivo results have shown the capability of these 
stem cells not only in bone tissue, but also in adipose tissue, dentin-like tissue, cartilage, hair bulb, 
nerves fibres40. In particular, DPSCs and SHEDs have been successfully applied for bone regeneration 
not only in animal models but also in human being41-43. 
In addiction, the presence of DPSCs have been investigated from tissues harvested from fractured teeth, 
teeth with caries or irreversible pulpitis, or aggressive periodontitis44-47. 
 
1.5 Gingival mesenchymal stem cells 
Gingival tissue is composed of an epithelial layer and underlying lamina propria; as well as dental pulp 
and all the other craniofacial tissues of mesenchymal origin, these tissue develops from the cranial 
neural crest48. 
Gingival mesenchymal stem cells (GMSCs) have been isolated more recently than DPSCs, indeed, 
GMSCs were firstly described by Zhang et al. in 200949.  
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The GMSCs are a subpopulation of the gingival fibroblast and exhibited all the MSCs characteristics: 
self-renewal capability, multipotent differentiation, and immunomodulatory abilities both in vitro and 
in vivo49,50. 
It has been demonstrated that GMSCs are more superior to BM-MSCs: GMSCs are uniformly 
homogenous, proliferate faster than BM-MSCs without any growth factor, display stable phenotype, 
maintain normal karyotype and telomerase activity, and are not tumorigenic51-53. 
Clinically, it is extremely simple to collect gingival tissue by biopsy, contrary to pulpar or periodontal 
cells that require tooth extraction for harvest50,52. Furthermore, the regeneration of gingival anatomy 
usually takes place in a short time period after wounding, usually lead to a perfect healing of the gum 
without complication for the patients, representing another advantage50,52.  
Similar to other MSCs, GMSCs cultures can be induced to differentiate into osteo-, adipo- and 
chondrogenic lineages as well as to myofibroblasts in vitro54. Noteworthy, experimental studies have 
proved that GMSCs possess also the capability to develop mineralized tissues in vivo55-57. 
In addiction, as well as for the DPSCs, the presence of GMSCs has been proved also in inflamed and 
hyperplastic tissues53,58.  
 
1.6 Scaffolds 
Not only the source of the cells is important but also the design and the formation of a structure able to 
support the migration and growth of cells is essential to achieve new tissue formation25,59. 
To achieve bone tissue regeneration is needed the use of a suitable scaffolds; the major function of 
scaffolds is to furnish temporary structural support for osteoprogenitor cells, and osteoinductive factors 
desired to repair bone defect25,59. 
Scaffolds are principally biodegradable, synthetic, three dimensional (3D) structures, emulating the 
extracellular matrix and containing macro- and micro-pores that guide cell adhesion, proliferation and 
differentiation60,61. 
To secure a high density of colonizing cells and to promote neovascularization when implanted in vivo, 
the scaffolds should possess excellent mechanical properties, extensive surface area and pore size 
distribution along with highly interconnected porous structure62,63. 
Thermally induced phase separation (TIPS) can be used to produce a well interconnected porous 
scaffold; indeed, this technique allows to obtain different porous materials as scaffold architectures 
simply changing one or more experimental processing parameters and system properties61,64.  
“TIPS technique is based on thermodynamic demixing of a homogeneous polymer-solvent solution into 
a polymer-rich phase and a polymer-lean phase, usually by either exposure of the solution to another 
immiscible solvent or cooling the solution below a binodal solubility curve”64. 
Various polymers have been employed to create scaffolds by mean of TIPS technique; Poly(L-lactide) 
(PLLA) has been extensively used as a scaffold material for bone tissue engineering due to its superior 




The aim of the study is to provide the evidence of a new potential sources of MSCs for bone 
regeneration in dentistry. The DPSCs and the GMSCs were isolated from periodontally compromised 
teeth and their corresponding inflamed gingiva (P-DPSCs and P-GMSCs).  
The inflammatory effects on human dental stem cells has been evaluated; we compared the MSCs 
markers, MSCs gene profile, proliferation and in vitro differentiation ability of the P-DPSCs and P-
GMSCs compared to healthy teeth (H-DPSCs and H-GMSCs). We investigated if pro-inflammatory 
microenvironment negative affects dental MSCs characteristics and their capability and we speculated 
about a closer link between chronic inflammation and bone formation.  
Furthermore, we evaluated the capability of P-DPSCs and P-GMSCs to develop vital bone tissue in 
vivo, in comparison to H-DPSCs and H-GMSCs.  
In addiction, P-DPSCs and P-GMSCs, as well as H-DPSCs and H-GMSCs, have been seeded on 3D 
PLLA scaffolds obtained with the TIPS technique to study their ability to form new mineralized bone 


































All the procedures reported were approved by the Internal Ethical Committee of the University 
Hospital A.U.O.P “P. Giaccone” of Palermo (Internal registry: 5/2014). Patients signed an informed 
consent form before recruitment for the study. 
 
2.2 Dental pulp and gingival tissue extraction  
Dental pulp was extracted from teeth of healthy adults aged 18-75 years. 
The eligibility criteria for participants were the following: extraction needed for molars suffering from 
severe periodontal disease (mobility grade III) (Test group), extraction needed for wisdom teeth for 
orthodontic reasons (Control group), no suspected or visible pregnancy in females, positive response to 
the vitality test performed on teeth to be extracted. 
Before extraction, each patient had to rinse his or her mouth with 0.2% chlorhexidine for one minute 
(Meridol®, Gaba Vebas S.r.l., Rome, Italy) to decontaminate the oral cavity. Gingival tissue was 
collected while the patient underwent oral surgery procedures for tooth extraction. 
 
2.3 Establishment of pulp dental and gingival cell cultures  
All the samples were processed by Professor Giordano’s research group (Laboratory of Regenerative 
Medicine (DIBIMIS)). 
After surgery the pulpal or the gingival tissue was transferred to an RPMI culture medium (Sigma -
Aldrich, Milano, Italy) enriched with 0.2 mg/ml gentamicin, 0.25 mg/ml levofluoxacin, 0.10 mg/ml 
vancomicin, 0.25 mg/ml fluconazole in a 50 ml tube and within 24 hrs the samples were digested. 
Digestion was carried out in a solution of 5 mg/ml collagenase G (Abiel, Palermo, Italy) and 2 mg/ml 
collagenase H (Abiel, Palermo, Italy), 4:1 respectively, 4 hrs at 37°C, in agitation. The digests 
containing primary cells from the pulp or the gingiva were centrifuged and transferred to a T25 cell 
culture flask (EuroClone, Milano, Italy) or a p60 dish culture (to which we referred as passage 0, p0). 
The cells were maintained in culture in RPMI culture medium enriched with 0.5µg/ml gentamicin, 
0.25µg/ml levofluoxacin, 0.10µg/ml vancomicin, 0.25µg/ml fluconazole and 5% fetal bovine serum 
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and incubated at 37°C, in 5% of CO2. Primary cells were attached to the flask within 4-5 days. Once 
they reached 80% of confluence (in about two weeks) they were trypsinized and the subculture was 
started (passage 1, p1). By subculture p4 the antibiotic and anti-fungal cover was abolished (Expansion 
Medium: EM). The p1–p8 cells were used for the in vitro assays.  
 
2.4 Colony-forming assay 
To assess the colony-forming efficiency of the dental pulpal mesenchymal stem cells (DPSCs) and 
gingival mesenchymal stem cells (GMSCs), single-cell suspensions (p0) from the periodontally-
compromised teeth and healthy donors were seeded in a six-well culture in RPMI with 10% FBS at a 
density of 300 cells/well and cultured at 37°C and in 5% of CO2. After 14 days, the cells were fixed in 
4% paraformaldehyde, stained with 0.1% crystal violet. Only the cellular groups containing more than 
50 cells were considered as colonies. 
 
2.5 Cell proliferation curve and Population Doubling (PD) 
Proliferation was assayed by Trypan blue (Sigma-Aldrich), according to the manufacturer´s 
instructions. The p2 GMSCs or p2 DPSCs from Healthy (H) or Periodontally-compromised (P) donors 
were seeded at a density of 4x103 cells/cm2. The p4 H-DPSCs or p4 H-DGMSCs with or without 
20ng/ml IL-1β and 40ng/ml TNF-α were seeded in a 96-well culture at a density of 4x103 cells/cm2 
cells and cultured up to 120 hours. The cell counts were performed by optical microscope observation 
after trypan blue staining every 24 hours during the incubation period. The doubling time (DT) was 
calculated according to the literature data (Roth V. 2006 on the website http://www.doubling-
time.com/compute.php.). Three sets of experiments for each sample were used for calculations. 
 
2.6 Cytokine toxicity assay 
The p4 H-GDPSCs or p4 H-DGMSCs with or without 20ng/ml IL-1β and 40ng/ml TFN-α were seeded 
in a 96-well culture at a density of 4x103 cells/cm2 cell and cultured for up to 72 hours. Cell viability 
was evaluated by UV absorption spectrum at 550 nm at 24, 48 and 72 hours using a micro-plate reader, 
after 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) incubation for 4 hours at 
37°C. Bone Marrow-derived Mesenchymal Stem Cells (BM-MSCs) were used as positive control. 
 
2.7 Cell cycle cytofluorimetric analysis 
Single cell suspensions of H-DPSCs, P-DPSCs or H-GMSCs and P-GMSCs were obtained and DNA 
content analysis was performed, according to Nicoletti’s protocol. Briefly, 1x106 cells were fixed in 
70% ethanol, rehydrated in PBS and then resuspended in a DNA extraction buffer (with 0.2 M 
NaHPO4, 0.1% Triton X-100 and, pH 7.8). After staining with 1µg/ml of propidium iodide (PI) for 5 
minutes, fluorescence intensity was determined with a FACS Calibur flow cytometer (Becton-
Dickinson, New Jersey, USA). Data acquisition was performed with CellQuest (Becton Dickinson) 
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software, and the percentages of G1, S, and G2 phase cells were calculated with the MODFIT-LT 
software program (Verity Software House, Inc.). The Proliferation index (PI) was expressed as % G2 + 
% M. 
 
2.8 Surface marker cytofluorimetric analysis 
The H-DPSCs, P-DPSCs or H-GMSCs and P-GMSCs were harvested and filtered through a 40µm 
filter mesh and suspended at the concentration of 1x106 cells/ml. Then 100 µl of cell suspension 
containing 5x105 cells were used for each cytofluorimetric test. 
 
2.9 Flow cytometric Immunophenotyping 
Human anti-HLA-DR, human anti-CD34, human anti-CD45 monoclonal antibodies were tested on H-
DPSCs, P-DPSCs or H-GMSCs and P-GMSCs and were detected with the appropriate secondary 
antibody (Table 1). The incubation conditions were in accordance with the manufacturer’s instructions. 
Unstained cells were used as a negative control. BM-MSCs were used as a positive control. 
 
2.10 Stem cell phenotype 
The cells were tested for expression of Stro-1, CD146 and CD29 and SSEA4 surface MSC markers, 
with the appropriate human anti-monoclonal antibody. The antibody dilution, incubation and detection 
conditions are shown in Table 1. 
All reaction mixtures were then acquired with a FACS Calibur flow cytometer (Becton-Dickinson, 
New Jersey, USA) and analyzed with the CellQuest Pro software. Unstained cells were used as 
negative control. 
Isolation of total RNA, Reverse-PCR, Real Time PCR and semi-quantitative PCR Total RNA was 
extracted and purified using the E.Z.N.A. Total RNA Kit I (Omega Bio-Tek Inc Georgia, USA) 
according to the manufacturer’s instructions. RNA quantity and quality were assessed using Nano Drop 
2000 (Thermo Scientific); 2µg of MSC total RNA were reverse-transcribed to cDNA in a volume of 
20µl with Oligo dT primers (Applied Biosystems, California, USA) and the Reverse Transcriptase 
Rnase kit (Improm II, Promega, Wisconsin, USA).  
 
2.11 Real-time quantitative PCR (qRT-PCR) 
qRT-PCR primers were purchased from Qiagen (QuantiTect® Primer Assays, Qiagen, Milan, Italy) 
and Eurofin MWG (Biotech, Germany) and are listed in Table 2. All reactions were performed using 
the Quantitect SYBR Green PCR Kit (Qiagen, California, USA) using the RotorGene Q Instrument 
(Qiagen, California, USA). Each cDNA sample was mixed with specific primer sets and PCR master 
mix. The PCR reactions were performed using the following parameters for 40 cycles: denaturation at 
95°C for 3 minutes, 95°C for 20 seconds, annealing at 60°C for 30 seconds and elongation at 72°C for 
60 seconds. Reactions were performed at least in triplicate. The specificity of the amplified products 
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was determined by the melting peak analysis. The relative quantification model with efficiency 
correction was applied to normalize the expression of the target gene to β-actin (used as a housekeeping 
gene) and to compare gene expression with BM-MSCs (used as a positive cell control), on Rest2009 
software (Relative Expression Software Tool, Qiagen)33. The results were described as histograms 
using the GraphPad Software, Inc., California. 
qRT-PCR analysis for the stem genes was also performed after pro-inflammatory cytokine treatment: 
H-DPMSCs or H-GMSCs were incubated with 20ng/ml IL-1β and 40ng/ml TNF-α up to 72 hours. The 
forward (F) and reverse (R) primer sequences used for the reactions of amplification are listed in 
supplemental materials (Table 2). 
 
2.12 Semi-quantitative PCR 
To determinate the expression of runx-2 (Runt-related transcription factor 2) and actin-depolymerizing 
factors (ADFs):1µl complementary DNA was added to a 50µl reaction containing 5µl 10x reaction 
buffer, 50mmol/L MgCl2, 1µl dNTPs, 50pmol sense and anti-sense primers and 0.5 U Taq Gold DNA 
polymerase. The reactions were carried out according to the following protocol: I) 95°C for 10 minutes, 
II) 35 cycles at 95°C for 45 seconds, III) primer-specific annealing temperature for 45 seconds, IV) 
72°C for 45 seconds, V) a final extension cycle at 72°C for 7 minutes, followed by a termination cycle 
at 4°C. 
The primers were purchased by MWG and the sequences were the following: runx-2 F: 5’-
TACGACTGGACGCTGGTGC-3’, R: 5’-TTCATGGGTCGCTTGACGT-3’; Profilin-1 (Pfn-1) F: 5'-
ACCCGGAAACAAGAAGAC-3', R: 5'-ACTGGTCCGATAACCTCCCA; Cofilin-1 (Cfl-1) F: 5'-
TGCGGCTCCTACTAAACGG-3', R: 5'-ACGCACCTTCATGTCGTTGA-3'; Vinculin (Vcl) F: 5'- 
ATGTCTCCTATATCCTGGTTTTTGT-3', R: 5'-GCAGGAAGTGTCCTTCAGAC-3' 
The protein-interaction networks (PIN) 
Network analysis was performed on the heat shock proteins (HSPs) and ADFs using the STRING 
(Search Tool for the Retrieval of Interacting Genes/Proteins) found at the website <http://string-
db.org/>. 
 
2.13 Bone in vitro formation 
5x103/cm2 H-DPSCs or H-GMSCs were incubated in EM with 20ng/ml IL-1β and 40ng/ml TNF-α 
(cytokine precondition treatment). After 72 hours the medium was replaced with homemade osteogenic 
differentiation medium (ODM). 5x103/cm2 H-DPSCs, P-DPSCs or H-GMSCs and P-GMSCs were 
cultured in ODM. After 21 days of culture in the ODM, the cells were stained with Alizarin Red S 
(Sigma-Aldrich, St. Louis, USA) to detect calcium deposits. Briefly, the medium was removed and the 
cells were fixed with 4% formaldehyde solution for 30 minutes, and after fixation rinsed twice with 
distilled water and stained with 2% Alizarin Red S (pH 4.2) for 3 minutes. After observation under a 
light optical microscope, the images were acquired by Nikon DS-fi1 cam and for quantification of the 
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calcium deposits ImageJ software was used (https://imagej.nih.gov/ij/docs/concepts.html). The ODM 
consisted of DMEM supplemented with 15% FBS, 10-4 mM dexamethasone (Sigma-Aldrich, St. 
Louis, USA), 10 mM glycerophosphate (Sigma-Aldrich, St. Louis, USA) and 0.05 mM ascorbic acid 
(Sigma-Aldrich, St. Louis, USA)24.  
 
2.14 PLLA Scaffold preparation 
The Poly-L-lactic Acid (PLLA) scaffolds were produced by Professor Brucato’s research group 
(Department of Civil, Enviromental, Aerospace, Materials Engineering (DICAM) of the University of 
Palermo). 
Thermally Induced Phase Separation technique (TIPS) was employed in order to produce well 
interconnected porous structure, following procedures already reported in literature64,68. 
A homogeneous ternary solution composed of PLLA, dioxane and deionised water was prepared with a 
constant dioxane to water ratio of 87/13 (wt/wt); the polymer concentration was chosen to be 4% 
(wt/wt). The cloud point of the solution was at 40°C, so the solution was initially kept at 60°C. 
In order to establish the ideal porous structure for the DPSCs e GMSCS cells, different scaffold were 
prepared with different thermodynamic pathways and related different microporous structures. 
All the scaffolds were prepared using a cylinder aluminium sample holder (diameter 6 mm, height 30 
mm). 
The first two types of scaffolds were prepared using a binodal de-mixing technique; first the solution 
was hot poured into the sample holder, then the sample holder was immersed into a thermostatic water 
bath, in order to suddenly decrease the temperature to 30°C (scaffold a) or 25 °C (scaffold b) for 15 
min (de-mixing time),  
Subsequently, in order to freeze the as-obtained structures, a quench by pool immersion in an ethyl 
alcohol bath at a temperature of -20°C for 15 min was performed. Then, the scaffolds were extracted 
from sample holder, washed into deionised water for 24h and dried at 20°C under vacuum overnight, in 
order to completely eliminate any solvent trace. 
The microporous structure of the obtained scaffolds were approximately 150 µm (scaffold a) and 50-70 
µm (scaffold b). 
After the initial in vitro studies, a different protocol was adopted consisting of a spinodal 
decomposition technique (scaffold c). This procedure was slightly different from the first described 
before. After that the sample holder was filled with the ternary solution, it was immersed into a 
thermostatic water bath at 0°C for 10min; afterwards a teflon coating was applied and the as-obtained 
structure was cooled in an ethanol bath at -20°C for 15 min. The as-obtained structure were then 
washed and dried as described before. With this second technique achieved scaffolds with 5-20 µm 
micropores were achieved. 
 
2.15 Scaffold characterization before seeding 
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Due to the cylindrical shape of the sample holder, the cylindrical 3D scaffolds were cut to obtain disks 
of a diameter of 6 mm and thickness of 2 mm. 
The disks were sterilized in 70% ethanol (v/V) solution under vacuum for 18 h; subsequently four 
washes were carried out using with sterile PBS, to remove all the ethanol. 
A solution of collagen (type I solution from rat tail,) in acetic acid (0.02N) at the concentration of 
200µm/ml was prepared to coat the scaffolds, the solution was filtered with 0,2 µm filters. 
To achieve the collagen coating, the scaffolds were immersed in the obtained solution for 90 min at 
37°C. Afterwards the scaffolds were washed with PBS and kept in culture medium until the cell 
seeding. 
 
2.16 GMSCs seeding 
To text the capability of the MSCs chosen in this project, initially it was decided to employ only the P-
GMSCs. 
The in vitro test was conducted by seeding a cell suspension, at density of 1x105 GMSCs, on the top of 
scaffolds a and b (respectively with 150 and 50/70 µm micropores). 
After the seeding the scaffolds were incubated at 37°C for 90 min without the culture medium to 
promote the cell adhesion; then the scaffolds were placed into 24-well plates and 1ml of complete 
DMEM was added. Incubation was left at 37°C and 5% of CO2.  
The same procedures were applied to test the scaffolds c; regarding this second in vitro examination, 
two different volume of the solution containing the P-GMSCs were used: 20 µl and 15 µl. 
Viability of the P-GMSCs was investigated at established points (after 12h, 40h and 120h). 
 
2.17 Cell Counting Kit-8 assay 
The Cell Counting Kit-8 (CCK-8) assay was utilized to detect the viability of P-GMSCs seeded on 
scaffolds a and b. The scaffolds were placed in 96-well plates, and the absorbance at 450 nm was 
detected at 1–6 days after seeding.  
 
2.18 Alamar Blue cell viability assay 
The scaffolds c were transferred into new 24-well plates with 500 µl of Alamar Blue solution and 
DMEM, then plates were incubated for 3h at 37°C. 
Then the solution incubated with the scaffolds was transferred in a 96-well plates (100 µl) and the 
fluorescence was evaluated by a spectrophotometer. 
 
2.19 Cell vitality assay 
To text the cell vitality assay of scaffolds c were used Acridine orange (AO) and ethidium bromide 
(EB). The dye mix for the EB/AO staining was 100 µg/ml acridine orange and 100 µg/ml ethidium 
bromide in PBS. 
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The scaffolds tested were firstly placed in new 24-well plates and washed four times with PBS (100 µl), 
every wash cycle was of 5 minutes by mean of an oscillating surface.  
EB/AO dye mix (30 µl) was added to each well for 5 min, and cells were viewed under the 
fluorescence microscope using FITC and TRITC filters.  
 
2.20 DAPI assay 
The investigated scaffolds were placed in 24-well plates and washed three times with PBS (100 µl); 
then the scaffolds were fixed in 3,6% formaldehyde in PBS for 15 minutes. After washing in PBS, 
samples were stained with 1:100 µl DAPI in PBS for 1 minute, finally the scaffolds were observed 
under the fluorescence microscope. 
 
2.21 In vivo implantations 
All experimental procedures and protocols were approved by the “OPBA – Organismo Preposto al 
Benessere degli Animali” of the “A.Mirri” Experimental Zooprophylactic Institute of Sicily (approval 
No. 1061/2015) and by the Italian Minister of Health (approval No.1185/2015). 
All the surgical procedures were performed at the “A.Mirri” Experimental Zooprophylactic Institute of 
Sicily. 
6-week-old immunodeficient nude mouse (NU/NU) were used for the study, in each mouse were 
injected subcutaneously on the dorsal surface (n=2 per mouse) the cells suspension (fig.1). 
In detail, in the first trial, approximately 105 cells of DPSCs or GMSCs from healthy and periodontal 
donors were suspendend in 100µl of differentiation medium, for each group were prepared one 
suspension with osteogenic differentiated cells and one suspension with undifferentiated cells, as 
control. Indeed, four mice were used to text the capability of the cells to differentiate in vivo. 
Mice were sacrificed and dissected at 4 weeks after cell transplantation. 
In the second trial, the number of cells suspended were raised to 2x105 cells as well as the volume of 
the solution, that was raised to 200 µl. For each group were prepared the same suspensions, and four 
mice were used also for this text. 
Mice were sacrificed and dissected at 8 weeks after cell transplantation. 
 
2.22 Statistical analysis 
All assays were performed in triplicate. The data were reported as means ± SD and compared using the 
appropriate version of Student’s unpaired t-test or One way Anova analysis of variance and post 













3.1 Inflamed dental tissue-derived MSCs 
The DPSCs and GMSCs were isolated from 49 patients. The subjects were divided into two major 
groups: 1) periodontally-compromised group (P, n=37, test group) and 2) healthy group (H, n=12, 
control group). For each patient pulpal and gingival tissues were extracted. Nine of the total samples 
(n=5 test group; n=4 control group) were unsuccessfully processed, because of a high grade of bacterial 
contamination. For all 40 samples, after enzymatic digestion a cell suspension was generated. The first 
plastic adherent cells were detected from all cultures within seven or ten days of preparation. Initially 
primary cells from healthy tissue grew faster than those from test group. The cell cultures (p0) appeared 
heterogeneous in shape and size, and the cells showed the ability to grew out from tissue no totally 
digested and to form a clone-like growth (Fig.2 a-b, e-f). Generally, in culture progress, gingival cells 
reached confluence at day 15 (12-18 days) and pulpal cells at day 20 (14-26). All the primary cells 
showed typical fibroblast-like morphology and they were homogeneous in shape and size (Fig.2 c-d, g-
h). 
After they reached confluence, the cells were harvested and sub-cultured. From culture p1, a modest 
change in growth behaviour was observed: although the MTT assay revealed no difference (p< 0.05) in 
the growth rate, the P-DPSCs and P-GMSCs proliferated faster than healthy control cells. The doubling 
time (DT) was established at 34.37 ± 5 hrs vs. 28.83 ± 2 hrs for H-DPSCs vs. P-DPSCs, respectively; 
and at 29.13 ± 4 hrs vs. 26.22 ± 8 hrs, for H-GMSCs vs. P-GMSCs, respectively. The cell cycle 
analysis assigned a proliferation index (P.I.) G2M+S of 7.7% vs. 3.43%, respectively for P-DPSCs vs. 
H-DPSCs and a P.I. of 23.85% vs. 10.2%, respectively for P-GMSCs vs. H-GMSCs. The difference in 
P.I. H-DPSCs vs. P-DPSCs and H-GMSCs vs. P-GMSCs was statistically significant (Fig.3). 
 
3.2 Test and control dental pulp and gingival cell express putative mesenchymal stem cells markers; 
they were negative for hematopoietic differentiation clusters and showed a stem gene profile 
The isolated cells did not display any hematopoietic surface markers (CD34 and CD45) and HLA-DR. A 
slight increment was detected in the expression level of CD34 in test group, but was not statistically 
significant (p>0.005) (Fig.4). We analyzed the expression of putative mesenchymal surface stem cell markers 
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Stro-1, CD146, CD29 and SSEA4 by flow cytometry, compared to BM-MSCs (positive control, not showed) 
(Fig.5). In all samples, CD29 remained highly positive (about 100%). A higher Stro-1+/CD146+/SSEA-4+ 
cell population was detected in P-DPSCs and P-GMSCs than in the respective healthy controls (p<0.05) 
(Tab.3). 
We compared the stem molecular expression pattern in the H-DPSCs and H-GMSCs, P-DPSCs and P-
GMSCs. Expression analysis showed significant differences in ABCG2, CD105 and in OCT4 and SOX-2 
mRNA levels in GMSCs vs. DPMSCs, and in P-GMSCs vs. H-GMSCs. Generally, the MSC markers were 
consistently more highly expressed in dental MSCs than in BM-MSCs (Fig.5c). 
 
3.3 The pro-inflammatory cytokine cocktail could facilitate dental pulp and gingival mesenchymal 
stem cells expansion in vitro 
We investigated the effect of pro-inflammatory cytokines IL-1β and TNF-α. 
After 72 hours of treatment, no cytotoxic effect on cells was detected and by contrast we found increased 
proliferation. In this connection, MTT analysis showed an increment in the percentage of vital cells and a 
decrease in DT was detected in H-DPSCs and H-GMSCs treated with IL-1β and TNF-α, miming a P-DPSC 
and P-GMSC proliferation curve (Fig.6 a-b). 
 
3.4 Inflammation and stem cell gene profile correlation 
To investigate whether the inflammation environment affects stem gene profile, a real-time PCR analysis was 
performed to compare H-GMSCs and H-DPSCs after 20ng/ml IL-1β and 40ng/ml TNF-α up to 72 hours 
treatment versus no treated H-GMSCs and H-DPSCs. In figure 6c and 6d, the histograms represent the 
mRNA levels expressed as a fold change (FC).  In cytokine-treated H-GMSCs and H-DPSCs all MSC 
markers showed an increase of about 1.5 FC respect to H-GMSCs and H-DPSCs. 
We found a statistically significant increase of about 1.52 and 1.37 FC in ABCG2, 1.19 and 1.6 FC in 
CD105, 1.18 and 1.77 FC in NANOG, 1.77 and 1.14 FC in OCT4, 2.89 and 1.83 FC in SOX-2, respectively 
in H-DPSCs plus cytokines vs. H-DPSCs and H-GMSCs plus cytokines vs. H-DPSCs (p<0.05). 
 
3.5 Bone in vitro formation: Inflammation – cytoskeleton modulation – osteogenesis 
To evaluate the effect of the inflammatory condition on osteogenic differentiation potential in vitro, H-
DPMSCs and H-GMSCs treated with IL-1β and TNF-α for 72 hours were cultivated in the ODM and 
compared to P-DPSCs and P-GMSCs not cytokine-treated. After 21 days of differentiation culture 
procedure, phenotype and gene analysis were performed. As shown in figure 7a and 7b the alizarin red-
positive area indicated a higher amount of calcium deposits in treated H-DPSCs, H-GMSCs and in P-
DPSCs, P-GMSC compared to their healthy controls. 
 
3.6 Inflammation increases the expression of differentiation-associated genes 
A computational STRING investigation brought to our attention an interaction between inflammation 
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and cytoskeleton remodeling (fig.7c). To investigate whether the increase in osteogenic potential was 
correlated with both alteration of inflammation-related gene expression and actin modulation, we 
examined several HSP and ADF genes. After ten days of osteoblastic differentiation culture the mRNA 
levels of runx2, vcl, cfn-1 and pfn-1, hsp90, hspA9 and txn-1 expression were observed. 
Confirming the higher osteogenesis in inflamed conditions, mRNA level increments of runx2 (specific 
osteoblastic nuclear factor) in P-DPMSCs, P-GMSCs and cytokine-treated dental MSCs were found. At 
the same time, we detected a decrease in cofilin-1 and profilin-1 expression and an increase in vinculin-
1, hsp90, hspA9 and txn-1 in P-DPMSCs, P-GMSCs and in treated dental MSCs (fig.7d-e). 
 
3.7 Scaffolds preparation and CCK assay 
A homogeneous ternary solution of L-polylactic acid (PLLA) was used to create porous scaffolds via 
TIPS technique. All the produced scaffolds were analysed by mean of the SEM. From the sample 
holder-like scaffold were made PLLA disks, with a diameter of 6 mm and a thickness of 2 mm. The 
surface analysis of the samples allowed to define the surface area available for each scaffold, which 
was approximately equal to 10 cm2. In addiction, before the cell seeding, all the scaffolds were 
sterilized, as described before, and coated with collagen type I (200µm/ml). 
The first scaffolds prepared (a and b) presented bigger micropores than scaffolds c, in detail: a) 150 µm, 
b) 50/70 µm, c) 5/20 µm.  
The decision to create scaffold with smaller micropores was taken after the CCK assay of the scaffolds 
a and b. Cell culture tests carried out on these supports showed a quick decrease of the number of 
viable P-GMSCs cells seeded on the surface of the scaffolds during the examined culture period (10 
days) (fig. 8).  
For these reason, new scaffolds with smaller pores, (5/20 µm), were produced.  
The new scaffolds presented smaller micropores and high degree of interconnection (fig 9 and fig 10). 
Moreover, due to the results of the CCK assay, it was decided to seed 75000 cells for scaffold; so a cell 
suspension with 1x105 P-GMSCs for microliter density was seeded on every scaffolds. All experiments 
were performed in triplicate 
 
3.8 2D Alamar Blue assay 
The observation of the P-GMSCs growth showed a slow growth, strictly dependent to the cell density 
in the plates. 
For that reason, in order to evaluate the ideal cell concentration to achieve a rapid cell growth on the 
scaffolds, a 2D Alamar Blue assay was carried out on P-GMSCs cells seeded at different 
concentrations.  
In the fig. 11, it is possible to observe the P-GMSCs cell growth at different times. It was possible to 
observe how this cell type tends to stretch to make contact with neighbouring cells, at low cellular 
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density. Moreover, some P-GMSCs assumed a more similar astrocytes-like phenotype, as shown in fig. 
12. 
The results in fig. 13 showed a faster cell growth when the cell concentration was greater the 7500 
cell/cm2. These data were essential to establish the ideal cell concentration for the successive seeding; 
additionally, it was define that the ideal dimension of the flasks was of 25 cm2. 
 
3.9 3D Alamar Blue assay 
The Alamar Blue assay, as described before, was used to evaluate the cell growth (fig. 14).  The data 
showed the continuous cell growth in the studied period (120h), in which there was a doubling of the 
cells number present in the scaffold c. Comparing this curve with the previous one, related to the 
scaffold a and b, it is evident the difference in terms of cell growth between the two groups of the 
scaffolds. 
 
3.10 AO/EB vitality assay 
The observation of the scaffolds c through fluorescence microscopy at 72h confirmed a high level of 
cell viability (fig. 15). Indeed the red spot, related to non-viable cells, are few and circumscribed to few 
areas of the examined scaffolds. 
 
3.11 DAPI assay 
By nuclear staining and fluorescence microscopy, it was possible to observe the P-GMSCs distribution 
on the scaffolds c. 
The acquired images, taken in different regions of the seeded scaffolds, showed that the cells are 
distributed homogeneously over the entire scaffold’s surface (fig. 16). 
  
3.12 In vivo studies 
In the first animal study group was not observed bone formation at 4 weeks after cells transplantation 
(fig.17). 
So, in the second study group, it was decided to increase the number of cells suspended, the volume of 
the cells suspension and the period of time before the sacrifice of the animals. Again, in the second 
animal study group was not observed bone formation at 8 weeks after cells transplantation (fig.18). 


















For decades now extraordinary interest has matured in the field of MSCs because of their 
differentiation potential, which has led them to be used in TE, RM and cell and gene therapy for 
clinical applications. The search is ongoing for the best MSC tissue source. The elective tissues for this 
purpose are bone marrow and adipose tissue, although isolation of these MSCs may be an invasive 
procedure for patients and donors. In view of this, the possibility of isolating MSCs from discarded 
tissue is a fascinating idea and MSCs from periodontally-compromised teeth could be a good 
alternative. Even though it has been shown in the literature that pro-inflammatory cytokines affect 
MSC properties, the effects of inflammation due to periodontitis and its progression on the 
characteristics of dental MSCs remain unclear47,58,69. 
In the present study, we confirmed the presence of MSCs in human dental pulp and gingival tissue 
harvested from periodontally-compromised teeth and for the first time, to the best of our knowledge, at 
the same time we compared simultaneously the stem features to DPSCs and the GMSCs harvested from 
healthy donors. The cells isolated from all groups showed a typical fibroblast-like shape and proved 
positive for the principle stem markers (Stro-1, CD46, CD29 and SSEA4) and they did not exhibit 
surface expression for any hematopoietic marker (CD34 and CD45). Our results suggest that the 
inflamed condition related to the periodontal status of the patients has no effect on dental MSC 
viability, whereas it seems to improve the growth ability and stem gene profile of DPSCs and GMSCs. 
This view is supported by pro-inflammatory cytokine precondition experiments that demonstrated that 
H-DPSCs and H-GMSCs are able to mimic P-DPSCs and P-GMSCs, displaying similar proliferation 
curves and gene expressions when treated with IL-1β and TNF-α.  
P-DPSCs and P-GMSCs show a clear higher expression of the cardinal stem nuclear markers 
(NANOG, OCT4 and SOX-2) and ABCG2 (superficial marker) compared to both H-DPSCs and H-
GMSCs and the internal positive control (BM-MSCs).  Moreover, our data about H-DPSCs and H-
GMSCs under pro-inflammatory conditions in vitro show that osteoblastic differentiation capacity is 
not only well preserved but also is significantly improved compared to not stimulated and is almost 
equal to the MSCs of the test group. This finding was confirmed by a more highly calcified 
extracellular matrix formation and a higher expression of runx2, a bone-specific transcription factor, in 
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the cytokine-treated H-DPSCs and H-GMSCs as well as in the P-DPSCS and P-GMSCs70-72. 
Furthermore, we found that in the inflamed environment the expression levels of profilin-1 and cofilin-
1 decreased, whereas vinculin and hsp90, txn-1 and hspA9 permit stabilization of actin filaments. 
It has already been shown that in inflammatory environments several mediators activate a set of 
biological processes such as cell survival, proliferation and cell differentiation in MSCs73-76. During 
lineage specific differentiation, human stromal stem cells exhibit significant changes in morphology 
and actin cytoskeleton organization77-82. ADFs bind to actin monomers and filaments, causing 
depolymerization of actin filaments and thus preventing their reassembly and decreasing osteoblastic 
differentiation82-86. Osteoblastic cytoskeleton reconstruction depends on the regulation of the actin 
polymerization status carried out by ADFs, including cofilin, profilin and vinculin87-89.  
 
In recent years, one of the most studied materials has been the PLLA, which, in the present study, was 
used to develop scaffold by mean of the TIPS technique. The scaffolds were prepared according to a 
previously published technique by Pavia et al64,68, allowing the formation of foams with an ordered 
multilevel structure and average micropores size ranging from 150 µm to 5/20 µm. 
After the first in vitro study on scaffold a (150 µm) and scaffold b (50-70 µm), we observed a quick 
decrease of the number of viable P-GMSCs cells seeded on the surface of the scaffolds during the 
examined 10 days of culture period. For these reason, a different protocol was adopted to devolp a new 
scaffolda smaller micropores (5/20 µm) and high degree of interconnection.  
Once we have defined the size of the micropores of the scaffold by mean of the 2D Alamar Blue assay, 
we evaluate the ideal cell concentration to achieve a rapid cell growth on the scaffolds. 
In the second in vivo study on scaffold c, P-GMSCs showed the capability to grow on PLLA scaffolds 
It was observed that P-GMSCs tend to assume an astrocytes-like phenotype and showed a faster cell 
growth when the cell concentration was greater the 7500 cell/cm2. These data were essential to 
establish the ideal cell concentration for the successive seeding. 
Due to the 3D Alamar Blue assay and the AO/EB vitality assay, the P-GMSCs have shown a good 
proliferation rate, a high level of cell viability and low cells mortality. 
Furthermore, due to the DAPI assay, it was possible to observe on homogeneous distribution of the P-
GMSCs on the scaffolds c. 
Indeed, it could be assumed that PLLA scaffolds with 5/20 µm micropores promote the adhesion and 
the replication of P-GMSCs.  
 
Regarding the in vivo study, in both the animals study groups were not presented any bone formation 
neither inflamed tissue formation, at 4 or 8 weeks. 
Probably these results are related to the unstable carrier chose for the implantation of the cells; the skin 
absorption of the suspension was to fast, not giving to the cells the time needed to induce bone 
formation in vivo. 
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New in vivo studies are ongoing: cells suspensions of H-DPSCs, P-DPSCs, H-GMSCs or P-GMSCs 
were seeded on new scaffolds, with the same characteristics of scaffold c. After one week of in vitro 
osteogenic differentiation, the scaffolds were transplanted subcutaneously on the dorsal surface of 6-
week-old immunodeficient nude mouse (NU/NU).  
 
In conclusion, our results confirm that the chronic inflammatory microenvironment existing in 
periodontitis does not negatively affect the number of P-DPSCs and P-GMSCs and their stem cell 
marker profile. Pro-inflammatory cytokines permit a higher osteogenic differentiation potential, 
controlling the fate of MSCs through several regulatory mechanisms involving remodeling of 
cytoskeleton and stress response processes. Our data need further confirmation using enriched P-
DPSCs and P-GMSCs engineered scaffolds with the same set of experiments as presented in this study 
(data in progress). The first results about the growth and differentiation potential of seeded cells “in and 
from” the inflammatory environment are very promising. In our experience, P-DPSCs and P-GMSCs 
appear to be a valid autologous MSC source. In addition, they are promising for in vivo applications in 
diseases with persistent inflammatory environment that generally harms the features and hinders the 
success of cell transplantation. From a clinical point of view, our findings confirm the feasibility of 









































LOCALIZATION MARKER	 CODE NUMBER	 DILUTION	 INCUBATION	
Stro-1, surface	 Thermo Fisher Sc,	
39-8401	 1:100	 Overnight (o/n), 	room temperature (r.t.)	
CD 146, surface	  Milteny Biotec,	
 130-092-851	 1:50	 30 min, room 
temperature	
CD 29, surface	  Milteny Biotec,	
 130-101-258	 1:50	 30 min, room 
temperature	
SSEA4, surface	  Milteny Biotec,	
 130-98-371 	 1:100	 30 min, room 
temperature	
CD-34, surface Santa Cruz, 
 sc-19621  
1:50 o/n , r.t. 
CD-45, surface Santa Cruz,  
sc-28369  
1:50 o/n , r.t. 
HLA-DR, surface Santa Cruz ,  
sc-18875 
1:50 o/n , r.t.	
SECONDARY ANTIBODY	 CODE NUMBER	 DILUTION	 INCUBATION	
AlexaFluor 488	 Life Technologies, 
Z25402	 1:50	 20 min, r.t.	
AlexaFluor 594	 Life Technologies, 
Z25007	 1:50	 20 min, r.t.	
 


























HSPA9 (mortalin)	 F:5'-TACAGCAGATGGTGAGCGAC-3' 
R:5'-TGCTGTGTGCCCCAAGTAAT-3' 
MWG	
TXN-1 (thioredoxin-1)	 F:5'- GTGAAGTCAAATGCACGCCA-3' 
R:5'-GCAGATGGCAACTGGTTATGT-3' 
MWG	












MSCs	 MESENCHYMAL STEM CELL MARKERS	
STRO-1	 CD146	 CD29	 SSEA4	
H-DPSCs	 12.30 ± 2.32 %	 18.95 ± 1.79 %	 99.07 ± 0.5 %	 18.31 ± 1.06 %	
P-DPSCs	 31.32 ± 3.32 %	 37.80 ± 4.79 %	 97.26 ± 2.38 %	 27.33 ± 2.71 %	
H-GMSCs	 10.61 ± 1.37 %	 73.34 ± 5.43 %	 96.64 ± 5.08 %	 17.72 ± 1.97 %	
P-GMSCs	 20.46 ± 2.18 %	 86.54 ± 3.76 %	 96.74 ± 3.68 %	 31.56 ± 2.54 %	
BM-MSCs	 6.25 ± 2.2 %	 44.89 ±  5.54 %	 97.21 ± 0.89%	 5.1 ± 1.53 % 	
 
Tab. 3 The MSCs marker level expressions in healthy and periodontally-affected DPSCs or GMSCs. 


















Fig. 2 Colony-forming unit assays and monolayer subculture: Representative image of pulpal or 
gingival mesenchymal stem cell colonies stained with crystal violet isolated from teeth of one healthy 
subject and one periodontal-affected patient. Figures a and b, e and f show the clone-like growth of H-
DPSCs and P- DPSCs, respectively. Figures c and d, g and h show the typical fibroblast-like 
morphology of H-GMSCs and P-GMSCs (40x). 
 
85x39mm (300 x 300 DPI) 
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Fig.3 Proliferation curve and cell cycle analysis: In the upper panel: a) Cell growth curve of H-DPSCs 
and P- DPSCs evaluated with Trypan blue viability assay; b) From the typical fibroblast-like cell shape 
the higher P- DPSCs cellular density at 72 hrs is evident (40x); (c-d) A representative comparative 
analysis between cell cycle distribution of H-DPSCs and P-DPSC. In low panel: e) Cell growth curve 
of H-GMSCs and P-GMSCs with Trypan blue viability assay; f) H-GMSCs and P-GMSCs at 72 hrs; 
the P-GMSC cell density is higher than that of H-GMSCs (40x); (g-h) A representative comparative 
analysis of proliferative activity cell cycle distribution of H-GMSCs and P-GMSCs. 
 







Fig.4 Immuniphenotype flow cytometric assay: Cells are negative for CD34, CD45 and HLA-DR. All 
fields are representative of one sample. The CD34 increment in a periodontal-affected sample was not 
statistically significant. 
 









Fig.5 Stem cell feature analysis: a) A representative flow-cytometric analysis of periodontal-affected 
pulpal or gingival MSCs (P-DPSCs and P-GMSCs) in comparison to healthy controls (H-DPSCs and 
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H-GMSCs); b) The scatter dot plot graph represents the expression levels of mesenchymal stem cell 
markers (STRO-1; CD146; CD29 and SSEA4); c) the histograms represent a comparative qRT-PCR 
analysis of nuclear (on the left) and surface (on the right) markers in H-DPSCs, P-DPSCs, H-GMSCs 
and P-GMSCs. Actin-β was used as the housekeeping gene. FC (fold change). The mRNA expression 
of all analyzed genes was normalized against BM-MSCs (positive control). 
 




Fig.6 Two cytokines promote H-GMSC and H-DPSC expansion. a) Cytotoxicity assay: H-DPSCs, H-
GMSCs without and after cytokine treatment; b) Cell growth curve of H-DPSCs and P-DPSCs without 
and after cytokine treatment evaluated with Trypan blue viability assay; c) Comparative analysis of 
nuclear (on left) and surface marker expression (on right) in H-DPSCs and H-GMSCs with or without 
cytokine treatment (20ng/ml IL-1β and 40ng/ml TNF-α for 72 hrs). 
BM-MSCs: positive control; β-actin: normalized gene. 
Mean values ± SD of all samples studied are reported. Error bars are based on 3 independent 
experiments. 
 




Fig.7 Bone in vitro formation: Inflammation – cytoskeleton modulation -osteogenesis: a) A 
representative image of Alizarin Red assay stained calcium deposits after 21 days of osteogenic 
differentiation of cultured H-DPSCs, H-GMSCs with or without cytokine treatment, P-DPSCs, P-
GMSCs and BM-MSCs (control); b) the bar graph represents the quantitative analysis of the alizarin 
positive area performed with ImageJ software; c) the graph represents the interaction between anti-
inflammatory and cytoskeleton-regulating proteins performed on http://string-db.org/ ; d) the gel lines 
represent the semi-quantitative PCR analysis for runx- 2, vinculin, profilin-1 and cofilin-1 (1: H-
DPSCs; 2:H-DPSCs + cyt; 3: P-DPSCs; 4: H-GMSCs; 5: H-GMSCs + cyt; 6: P-GMSCs; 7: Positive 
control. cyt:20ng/ml IL1β + 40ng/ml TNF-α); e) the bar graph represents hsp90, hspA9 and txn1 real-
time PCR analysis normalized to BM-MSCs control; (cyt: 20ng/ml IL-1β + 40ng/ml TNF-α). FC: fold 
change. 
 







Fig. 8 CCK assay: Cell culture tests carried out on these supports showed a quick decrease of the 
































































































Fig. 17 In vivo study: in the picture the dorsal surface of one mouse of the first animal study group, no 




Fig. 18 In vivo study: in the picture the dorsal surface of one mouse of the second animal study group, 
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